Blood Test Accurately Predicts Five-Year Alzheimer’s Risk
Summary: A new study establishes the long-term prognostic power of the blood-based biomarker p-tau217. The analysis reveals that asymptomatic individuals presenting with very high baseline p-tau217 concentrations face an absolute 38% risk of developing cognitive impairment within 5 years, escalating to 78% within 10 years. This predictive capability operates entirely independent of amyloid PET plaque … Read more